196 related articles for article (PubMed ID: 9829931)
1. Identification and characterization of SpcU, a chaperone required for efficient secretion of the ExoU cytotoxin.
Finck-Barbançon V; Yahr TL; Frank DW
J Bacteriol; 1998 Dec; 180(23):6224-31. PubMed ID: 9829931
[TBL] [Abstract][Full Text] [Related]
2. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
Finck-Barbançon V; Goranson J; Zhu L; Sawa T; Wiener-Kronish JP; Fleiszig SM; Wu C; Mende-Mueller L; Frank DW
Mol Microbiol; 1997 Aug; 25(3):547-57. PubMed ID: 9302017
[TBL] [Abstract][Full Text] [Related]
3. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.
Allewelt M; Coleman FT; Grout M; Priebe GP; Pier GB
Infect Immun; 2000 Jul; 68(7):3998-4004. PubMed ID: 10858214
[TBL] [Abstract][Full Text] [Related]
4. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review.
Sawa T; Shimizu M; Moriyama K; Wiener-Kronish JP
Crit Care; 2014 Dec; 18(6):668. PubMed ID: 25672496
[TBL] [Abstract][Full Text] [Related]
5. Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model.
Lee EJ; Cowell BA; Evans DJ; Fleiszig SM
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3892-8. PubMed ID: 12939306
[TBL] [Abstract][Full Text] [Related]
6. Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU.
Lee VT; Pukatzki S; Sato H; Kikawada E; Kazimirova AA; Huang J; Li X; Arm JP; Frank DW; Lory S
Infect Immun; 2007 Mar; 75(3):1089-98. PubMed ID: 17178785
[TBL] [Abstract][Full Text] [Related]
7. Cloning and sequence analysis of a trans-regulatory locus required for exoenzyme S synthesis in Pseudomonas aeruginosa.
Frank DW; Iglewski BH
J Bacteriol; 1991 Oct; 173(20):6460-8. PubMed ID: 1655713
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional analysis of the Pseudomonas aeruginosa exoenzyme S structural gene.
Yahr TL; Hovey AK; Kulich SM; Frank DW
J Bacteriol; 1995 Mar; 177(5):1169-78. PubMed ID: 7868588
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of exsC and exsB in regulation of exoenzyme S production by Pseudomonas aeruginosa.
Goranson J; Hovey AK; Frank DW
J Bacteriol; 1997 Mar; 179(5):1646-54. PubMed ID: 9045825
[TBL] [Abstract][Full Text] [Related]
10. Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU.
Finck-Barbançon V; Frank DW
J Bacteriol; 2001 Jul; 183(14):4330-44. PubMed ID: 11418575
[TBL] [Abstract][Full Text] [Related]
11. Effector ExoU from the type III secretion system is an important modulator of gene expression in lung epithelial cells in response to Pseudomonas aeruginosa infection.
McMorran B; Town L; Costelloe E; Palmer J; Engel J; Hume D; Wainwright B
Infect Immun; 2003 Oct; 71(10):6035-44. PubMed ID: 14500525
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa.
Gendrin C; Contreras-Martel C; Bouillot S; Elsen S; Lemaire D; Skoufias DA; Huber P; Attree I; Dessen A
PLoS Pathog; 2012; 8(4):e1002637. PubMed ID: 22496657
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity.
Tam C; Lewis SE; Li WY; Lee E; Evans DJ; Fleiszig SM
Exp Eye Res; 2007 Dec; 85(6):799-805. PubMed ID: 17905228
[TBL] [Abstract][Full Text] [Related]
14. ExoU is a potent intracellular phospholipase.
Sato H; Frank DW
Mol Microbiol; 2004 Sep; 53(5):1279-90. PubMed ID: 15387809
[TBL] [Abstract][Full Text] [Related]
15. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa.
Shi H; Chen Z; Kan J
Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625
[TBL] [Abstract][Full Text] [Related]
16. Analyses of the DNA-binding and transcriptional activation properties of ExsA, the transcriptional activator of the Pseudomonas aeruginosa exoenzyme S regulon.
Hovey AK; Frank DW
J Bacteriol; 1995 Aug; 177(15):4427-36. PubMed ID: 7635828
[TBL] [Abstract][Full Text] [Related]
17. Acquisition and evolution of the exoU locus in Pseudomonas aeruginosa.
Kulasekara BR; Kulasekara HD; Wolfgang MC; Stevens L; Frank DW; Lory S
J Bacteriol; 2006 Jun; 188(11):4037-50. PubMed ID: 16707695
[TBL] [Abstract][Full Text] [Related]
18. Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis.
Zhu H; Conibear TC; Bandara R; Aliwarga Y; Stapleton F; Willcox MD
Curr Eye Res; 2006 Apr; 31(4):297-306. PubMed ID: 16603462
[TBL] [Abstract][Full Text] [Related]
19. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.
Yahr TL; Barbieri JT; Frank DW
J Bacteriol; 1996 Mar; 178(5):1412-9. PubMed ID: 8631719
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU.
Pankhaniya RR; Tamura M; Allmond LR; Moriyama K; Ajayi T; Wiener-Kronish JP; Sawa T
Crit Care Med; 2004 Nov; 32(11):2293-9. PubMed ID: 15640644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
